Clinical trial
Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
NCT00030069 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00030069 |
|---|---|
| Title | Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes |
| Official title | Calcitriol and Dexamethasone for Myelodysplastic Syndromes |
| Lead sponsor | University of Pittsburgh, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Calcitriol, Dexamethasone |
| Enrollment | 32 |
| Start date | Sep 1, 2001 |
| Primary completion | Sep 1, 2007 |
| Completion | May 1, 2009 |
| First posted | Jan 31, 2002 |
| Last update posted | Jan 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: